SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.

COVID-19 cardioncology cardiovascular diseases cytokines inflammation myocardial injury

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
10 Nov 2020
Historique:
received: 01 10 2020
revised: 05 11 2020
accepted: 08 11 2020
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 14 11 2020
Statut: epublish

Résumé

The coronavirus disease-2019 (COVID-19) is a highly transmissible viral illness caused by SARS-CoV-2, which has been defined by the World Health Organization as a pandemic, considering its remarkable transmission speed worldwide. SARS-CoV-2 interacts with angiotensin-converting enzyme 2 and TMPRSS2, which is a serine protease both expressed in lungs, the gastro-intestinal tract, and cardiac myocytes. Patients with COVID-19 experienced adverse cardiac events (hypertension, venous thromboembolism, arrhythmia, myocardial injury, fulminant myocarditis), and patients with previous cardiovascular disease have a higher risk of death. Cancer patients are extremely vulnerable with a high risk of viral infection and more negative prognosis than healthy people, and the magnitude of effects depends on the type of cancer, recent chemotherapy, radiotherapy, or surgery and other concomitant comorbidities (diabetes, cardiovascular diseases, metabolic syndrome). Patients with active cancer or those treated with cardiotoxic therapies may have heart damages exacerbated by SARS-CoV-2 infection than non-cancer patients. We highlight the cardiovascular side effects of COVID-19 focusing on the main outcomes in cancer patients in updated perspective and retrospective studies. We focus on the main cardio-metabolic risk factors in non-cancer and cancer patients and provide recommendations aimed to reduce cardiovascular events, morbidity, and mortality.

Identifiants

pubmed: 33182653
pii: cancers12113316
doi: 10.3390/cancers12113316
pmc: PMC7697868
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : This work was funded by an "Ricerca Corrente" grant from the Italian Ministry of Health. "Cardiotossicità dei trattamenti antineoplastici: identificazione precoce e strategie di cardioprotezione" Project code: M1/5-C

Références

N Engl J Med. 2016 Nov 03;375(18):1749-1755
pubmed: 27806233
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Nutrients. 2019 Sep 04;11(9):
pubmed: 31487871
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Curr Med Chem. 2018;25(11):1327-1339
pubmed: 28403786
PLoS One. 2015 Mar 25;10(3):e0119803
pubmed: 25807547
Front Immunol. 2019 Nov 01;10:2578
pubmed: 31736980
Ann Palliat Med. 2018 Apr;7(2):265-273
pubmed: 29307210
Nutrients. 2019 Sep 03;11(9):
pubmed: 31484340
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
N Engl J Med. 2003 May 15;348(20):1953-66
pubmed: 12690092
Respir Med Case Rep. 2019 Apr 15;27:100839
pubmed: 31024792
Curr Probl Cardiol. 2020 Aug;45(8):100618
pubmed: 32439197
Eur Heart J. 2012 Dec;33(24):3114-23
pubmed: 21804111
J Travel Med. 2020 May 18;27(3):
pubmed: 32186711
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9169-9171
pubmed: 32965010
J Hepatol. 2020 Aug;73(2):451-453
pubmed: 32278005
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):567-571
pubmed: 32141280
Case Rep Oncol Med. 2015;2015:794842
pubmed: 25918658
J Immunother Cancer. 2020 May;8(1):
pubmed: 32434790
Pract Neurol. 2020 Oct 8;:
pubmed: 33033161
Blood. 2008 May 15;111(10):4902-7
pubmed: 18216292
Circulation. 2003 Jun 3;107(21):2670-6
pubmed: 12742982
Endocr Relat Cancer. 2018 Sep;25(9):807-819
pubmed: 29773553
Arch Intern Med. 2011 Jun 27;171(12):1061-8
pubmed: 21321288
J Am Heart Assoc. 2020 Jan 21;9(2):e013757
pubmed: 31960755
J Rheumatol. 1994 Oct;21(10):1820-4
pubmed: 7837144
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Front Pharmacol. 2019 Nov 29;10:1350
pubmed: 31849640
Lancet Oncol. 2019 Oct;20(10):e566-e581
pubmed: 31492632
Circ Res. 2018 Jun 8;122(12):1722-1740
pubmed: 29880500
Cardiol Rev. 2020 Nov/Dec;28(6):308-311
pubmed: 32941261
Pediatr Blood Cancer. 2020 Jul;67(7):e28397
pubmed: 32383819
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Thromb Haemost. 2004 Dec;92(6):1250-8
pubmed: 15583730
J Clin Oncol. 2007 Sep 1;25(25):3859-65
pubmed: 17646669
Br J Clin Pharmacol. 2014 Oct;78(4):748-62
pubmed: 24661224
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Ann Oncol. 2020 Mar;31(3):352-368
pubmed: 32067678
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35
pubmed: 32232218
Crit Care. 2020 Apr 28;24(1):179
pubmed: 32345311
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):387-95
pubmed: 22697070
Br J Sports Med. 2016 Mar;50(6):339-45
pubmed: 26385207
Diabetes Res Clin Pract. 2020 May;163:108186
pubmed: 32360400
Ann Oncol. 2020 Aug;31(8):1040-1045
pubmed: 32387456
BMC Public Health. 2018 Jun 20;18(1):778
pubmed: 29925336
J Natl Cancer Inst. 2014 May 21;106(6):dju110
pubmed: 24848622
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
BMC Med Genet. 2020 Feb 11;21(1):29
pubmed: 32046680
Oncologist. 2018 Aug;23(8):879-886
pubmed: 29802219
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):792-802
pubmed: 23462914
Eur Heart J. 2020 May 7;41(18):1720-1729
pubmed: 32016393
J Cardiovasc Pharmacol. 2017 May;69(5):305-313
pubmed: 28207428
J Vasc Surg Venous Lymphat Disord. 2020 Oct 5;:
pubmed: 32979557
J Med Virol. 2020 Jun;92(6):688-692
pubmed: 32167166
Circ Res. 2016 Jan 8;118(1):145-56
pubmed: 26837745
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
JAMA Oncol. 2020 Jul 1;6(7):1108-1110
pubmed: 32211820
Surg Oncol. 2010 Mar;19(1):e33-46
pubmed: 19394816
Front Immunol. 2018 Jun 13;9:1335
pubmed: 29951067
Herz. 2020 May;45(3):230-232
pubmed: 32140732
Nat Rev Cardiol. 2018 Apr;15(4):203-214
pubmed: 29143812
Cancer Invest. 2004;22(3):401-4
pubmed: 15493361
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
J Natl Compr Canc Netw. 2016 Jul;14(7):882-913
pubmed: 27407129
Circ Cardiovasc Genet. 2014 Aug;7(4):444-54
pubmed: 25031303
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32611687
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
J Virol. 2011 May;85(9):4122-34
pubmed: 21325420
CMAJ. 2020 May 19;192(20):E551
pubmed: 32332038
Curr Cardiol Rep. 2020 Jun 11;22(7):52
pubmed: 32529517
JAMA. 1999 Jun 2;281(21):1998-2004
pubmed: 10359388
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Am J Clin Nutr. 2016 Sep;104(3):678-85
pubmed: 27488239
Int J Cardiol. 2019 Oct 1;292:171-179
pubmed: 31160077
PLoS One. 2015 Nov 10;10(11):e0142532
pubmed: 26555480
Arthritis Res Ther. 2018 Aug 3;20(1):169
pubmed: 30075804
G Ital Cardiol (Rome). 2018 Sep;19(9 Suppl 1):3S-6S
pubmed: 30284556
Eur J Cancer. 2020 Aug;135:242-250
pubmed: 32586724
Proc Nutr Soc. 2008 Aug;67(3):253-6
pubmed: 18452640
J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S19-26
pubmed: 27183521
Eur J Cancer. 2020 Jun;132:199-206
pubmed: 32380430
J Cardiol Cases. 2013 Oct 29;8(6):173-175
pubmed: 30534284
Nutrients. 2018 Sep 14;10(9):
pubmed: 30223482
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
J Thorac Oncol. 2020 Jun;15(6):e83-e85
pubmed: 32243919
Circ Cardiovasc Imaging. 2017 Sep;10(9):
pubmed: 28899951
Lancet. 2020 Mar 28;395(10229):1034-1035
pubmed: 32178767
Nurs Res. 2009 Mar-Apr;58(2):105-14
pubmed: 19289931
PLoS One. 2012;7(4):e35876
pubmed: 22558251
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Crit Rev Oncol Hematol. 2017 Dec;120:151-162
pubmed: 29198329
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2781-2783
pubmed: 32196628
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Circulation. 2018 Mar 13;137(11):1176-1191
pubmed: 29530893
Food Chem Toxicol. 2020 Sep 30;146:111769
pubmed: 32979398
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet Oncol. 2017 Jan;18(1):e19-e29
pubmed: 28049574
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Front Microbiol. 2018 Dec 12;9:3097
pubmed: 30619176
Eur J Heart Fail. 2019 Aug;21(8):965-973
pubmed: 31087601
Int Heart J. 2015 May 13;56(3):269-72
pubmed: 25902883
Immunotherapy. 2020 Apr;12(5):269-273
pubmed: 32212881
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JCO Glob Oncol. 2020 Apr;6:557-559
pubmed: 32250659
J Cardiovasc Med (Hagerstown). 2016 May;17 Suppl 1:S3-S11
pubmed: 27183523
Anatol J Cardiol. 2020 Aug;24(2):68-75
pubmed: 32749254
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
J Pers Med. 2020 Oct 19;10(4):
pubmed: 33086484
JACC CardioOncol. 2020 Jun;2(2):350-355
pubmed: 32292919
Cancers (Basel). 2020 Mar 20;12(3):
pubmed: 32245016
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
J Thromb Haemost. 2013 Feb;11(2):223-33
pubmed: 23279708
J Thromb Haemost. 2020 Jun 18;:
pubmed: 32558075
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Cardiovasc Res. 2019 Apr 15;115(5):854-868
pubmed: 30715219
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Curr Cardiol Rev. 2019;15(2):83-90
pubmed: 30378501
Clin Chim Acta. 2012 Mar 22;413(5-6):577-81
pubmed: 22146599
J Cardiothorac Vasc Anesth. 2020 Jun;34(6):1591-1601
pubmed: 32127272
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Tumour Biol. 2016 Sep;37(9):11553-11572
pubmed: 27260630
Mol Med. 2017 May;23:83-91
pubmed: 28362018
Lancet. 2019 Sep 21;394(10203):1041-1054
pubmed: 31443926
Drug Dev Res. 2020 Aug;81(5):537-540
pubmed: 32129518
Mol Endocrinol. 2013 Dec;27(12):2028-40
pubmed: 24109594
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2162-2164
pubmed: 32141586
PLoS One. 2019 Feb 22;14(2):e0212236
pubmed: 30794604
Biol Sex Differ. 2019 Sep 4;10(1):45
pubmed: 31484552
Biomed Res Int. 2018 Apr 1;2018:3058640
pubmed: 29805973
Br J Radiol. 2011 May;84(1001):e99-e102
pubmed: 21511746
Isr Med Assoc J. 2015 Jan;17(1):5-10
pubmed: 25739168
Leukemia. 2020 Jun;34(6):1637-1645
pubmed: 32332856
Circulation. 2003 Feb 11;107(5):690-5
pubmed: 12578870
Int Rev Immunol. 2020;39(1):3-10
pubmed: 31633447
J Am Coll Cardiol. 2012 Dec 18;60(24):2504-12
pubmed: 23158536
Ann Oncol. 2020 Aug;31(8):1088-1089
pubmed: 32330541
Am J Respir Crit Care Med. 2018 Jan 15;197(2):160-171
pubmed: 28930487
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981
Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):274-88
pubmed: 20109598
Lancet. 2012 Mar 31;379(9822):1205-13
pubmed: 22421339
Cancers (Basel). 2020 Aug 10;12(8):
pubmed: 32785162
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
N Engl J Med. 2000 Apr 13;342(15):1077-84
pubmed: 10760308
Circulation. 2019 May 21;139(21):e997-e1012
pubmed: 30955352
Lancet Oncol. 2018 Dec;19(12):1579-1589
pubmed: 30442497
J Am Coll Cardiol. 2019 Mar 26;73(11):1336-1349
pubmed: 30898209
Sci Rep. 2017 Oct 11;7(1):12934
pubmed: 29021577
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712

Auteurs

Vincenzo Quagliariello (V)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Annamaria Bonelli (A)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Antonietta Caronna (A)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Gabriele Conforti (G)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Martina Iovine (M)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Andreina Carbone (A)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Massimiliano Berretta (M)

Department of Medical Oncology-Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.

Gerardo Botti (G)

Scientific Direction, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Nicola Maurea (N)

Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

Classifications MeSH